CrushSCI.com
Journal Selection & Manuscript Polishing Services
PHARMACEUTICAL STATISTICS journal cover Medicine
Back to journal directory

Review Cycle Records

PHARMACEUTICAL STATISTICS

Wiley SCIE Non-OA
2026 Emerging Zone 42025 CAS Zone 42025 JCR Q2
281.6Average days
249.5Median days
109Fastest days
521Longest days
832025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

259 days

The Impact of Enrollment Strategies on the Performance of Time‐To‐Event Dose‐Escalation Designs for Phase I Drug Combination Oncology Trials

AuthorsXiaowen Tian; Michael Sweeting; Kristine Broglio

Affiliations1. Oncology Biometrics, Oncology R&D AstraZeneca Gaithersburg Maryland USA; 2. Oncology Biometrics, Oncology R&D AstraZeneca Cambridge UK

Source PDF DOI Publisher page
247 days

Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials

AuthorsYuxiang Wu; Xiaohan Guo; Ray Li; Christophe Le Corre

Affiliations1. Department of Biostatistics and Bioinformatics Emory University Atlanta Georgia USA; 2. Oncology Biometrics Pfizer New York New York USA

Source PDF DOI Publisher page
521 days

Use of Composite Priors for Assurance of Sequential Therapy Trials: Practical Experiences Using Binary Endpoint Data

AuthorsJonathan Wright; Li Ye

Affiliations1. GSK London UK; 2. GSK Upper Providence Pennsylvania USA

Source PDF DOI Publisher page
443 days

Applying the Promising Zone Method to Biomarker‐Based Adaptive Designs: A Word of Caution

AuthorsJingzhao Wang; Ruobing Li; Jun Zhao; Zhimin Tang; Jianhong Pan

Affiliations1. Office of Biostatistics and Clinical Pharmacology, Center for Drug Evaluation National Medical Products Administration Beijing China

Source PDF DOI Publisher page
308 days

Accelerated Stability Studies: A Frequentist–Bayesian Hybrid Simulation Approach Implemented in the AccelStab R Package

AuthorsBernard G. Francq; Nikolaos Giannelos; Raymundo Sanchez; Marilena Paludi

Affiliations1. GSK Rixensart Belgium; 2. GSK Collegeville Pennsylvania USA; 3. GSK Siena Italy

Source PDF DOI Publisher page
252 days

Robustness of the Pairwise‐Fitting Approach Under Missing at Random Dropout: A Case and Simulation Study

AuthorsDries De Witte; Geert Verbeke; Thomas Neyens; Ariel Alonso Abad; Geert Molenberghs

Affiliations1. L‐BioStat, KU Leuven Leuven Belgium; 2. I‐BioStat, UHasselt Diepenbeek Belgium

Source PDF DOI Publisher page
190 days

Degrees‐of‐Freedom Approximations for Conditional‐Mean Inference in Random‐Lot Stability Analysis

AuthorsAndrew T. Karl; Heath Rushing; Richard K. Burdick; Jeff Hofer

Affiliations1. Karl Statistical Services LLC Aurora Colorado USA; 2. Adsurgo LLC San Antonio Texas USA; 3. Burdick Statistical Consulting, LLC Colorado Springs Colorado USA; 4. JDH CMC Stats, LLC Avon Indiana USA

Source PDF DOI Publisher page
227 days

Seamless Phase I– II Cancer Clinical Trials Using Kernel‐Based Covariate Similarity

AuthorsKana Makino; Natsumi Makigusa; Masahiro Kojima

Affiliations1. Department of Data Science for Business Innovation Chuo University Tokyo Japan

Source PDF DOI Publisher page
109 days

A Cautionary Note on Regional Consistency Evaluation With Multiple Primary Endpoints in Multiregional Clinical Trials

AuthorsGosuke Homma

Affiliations1. Astellas Pharma Inc. Tokyo Japan

Source PDF DOI Publisher page
241 days

Dose Optimization Design for Randomized Phase II Trials With Toxicity and Efficacy Endpoints

AuthorsRyuta Tabata; Tomohiro Ohigashi; Takashi Sozu

Affiliations1. Department of Information and Computer Technology, Graduate School of Engineering Tokyo University of Science Tokyo Japan; 2. Department of Information and Computer Technology, Faculty of Engineering Tokyo University of Science Tokyo Japan

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.